Equities

SMI closes in the black as tech and chip stocks lead gains
The Swiss benchmark index added 0.1 percent, with Logitech, Galderma and ABB among the top risers, while Novartis, Nestle and Roche weighed on the index.

Stock Markets Face Uncertainty After Tech Correction Ahead of Year-End
Following a record high for the SMI and a subsequent Nasdaq correction, investors weigh seasonal trends against macroeconomic factors and artificial intelligence valuations.

UBS Swiss Real Estate Bubble Index Eases in Third Quarter
The UBS Swiss Real Estate Bubble Index declined in the third quarter, though overall bubble risk remains categorized as moderate.

DocMorris Shares Extend Gains After Upgrade and Medi24 Acquisition
DocMorris shares climbed further following an upgrade by Zürcher Kantonalbank and the planned acquisition of Swiss telemedicine provider Medi24.

Swatch and Richemont Shares Rise on Improved Watch Sector Outlook
Swatch and Richemont shares advanced following an improved full-year sales forecast from British retailer Watches of Switzerland.

PSP Swiss Property Posts Higher Nine-Month Profit on Project Sale
PSP Swiss Property reported an increase in operating profit for the first three quarters of 2026, driven largely by the sale of the Richtipark development project in Wallisellen.

Swiss Shares Close at Session Highs as Wall Street Gains on Oil Price Drop
The SMI closed 0.61 percent higher led by Roche and Sika, while US equities advanced following a decline in oil prices and remarks by Donald Trump regarding Iran.

Swiss Inflation Focus Turns to 13th AHV Pension and Tecan Shares Surge
Deutsche Bank evaluates inflation risks from Switzerland's upcoming 13th AHV pension, while Tecan shares rally following an analyst upgrade.

Analyst downgrades weigh on Munich Re and Hannover Rück shares in Frankfurt
JPMorgan downgrades push reinsurers down by about 4 percent each in Frankfurt trade, halting their recent rally amid upcoming pricing pressures.

SMI Under Pressure After Record High With Swiss Life and Zurich in Focus
US inflation data and corporate earnings from firms including Swiss Life, Zurich, and Richemont take center stage as the Swiss market retreats.

Deutsche Bank Tech Upgrade Precedes Market Slump, Lonza Acquires Merck Sites
Deutsche Bank upgrades the technology sector hours before a market pullback, while Lonza announces a multi-million franc acquisition of Merck production sites.

Rheinmetall Shares Plunge Over 17% Following Profit Warning
German defence group Rheinmetall cuts annual sales and profit margin forecasts due to delayed orders, pushing the wider European defence sector down.

Arbonia Shares Fall Following Target Cuts and Guidance Revision
Swiss building supplier Arbonia saw its shares decline after analysts lowered their price targets following a revenue and profit warning for 2026.

Frankfurt Stocks End Rally at Record High Amid US Market Turbulence
German equities retreated from record highs as US market turbulence and corporate earnings weighed on sentiment.

UBS shares dip 0.27% after Wednesday surge, market focus on capital rules and merger talk
UBS stock fell 0.27% to CHF 41.17 as the SMI rose, following a 4.59% jump on Wednesday driven by bank‑stock demand, US midterm results, capital‑rule proposals and Morgan Stanley merger speculation.

European equities rally after US midterms, DAX hits record high
European stocks rose on Thursday, with Germany’s DAX up 0.8% to a record 26,654.56 points and the Swiss SMI holding above 15,000, as optimism follows the US mid‑term results.

BMW Issues Second Profit Warning on Restructuring and Job Cuts
German carmaker BMW cuts its profit margin outlook and reports a drop in third-quarter earnings, citing restructuring costs and declining sales in China.

Swiss Market Index Crosses 15,000 Points for the First Time
The Swiss benchmark index climbed past 15,000 points on Wednesday, driven by gains in major heavyweights and the results of the US midterm elections.

Swiss Pharma and Chemical Sector Retains Global Standing but Trails in Innovation
A new BAK Economics study places Switzerland third globally in chemicals and pharmaceuticals, while noting vulnerabilities in clinical trials, AI adoption, and innovation.

Swisscom Expected to Post Higher Nine-Month Profit Despite Lower Revenue
Analysts forecast Swisscom will report lower nine-month revenue but higher earnings, driven by price hikes and integration synergies.

Swiss Prime Site Solutions Outlines Terms for Akara Fund's 18th Capital Increase
The real estate fund manager targets a volume of up to 170,658 new shares to finance secured acquisitions and ongoing development projects.

Swiss Shares Driven by Corporate News Rather Than US Midterms
Investors on the Swiss stock market show a subdued reaction to the US midterm elections as individual corporate developments drive market movements.

Swiss Market Index Closes Lower as Heavyweights Fall; Burckhardt Compression Jumps on Orders
The Swiss stock market ended Tuesday in negative territory, led lower by pharmaceutical giant Roche and plumbing supplier Geberit, while Burckhardt Compression surged.

J. Stern & Co. Completes Acquisition of Geneva Asset Manager bvo capital
Independent asset manager J. Stern & Co. has finalized its merger with bvo capital following regulatory approval from FINMA, expanding its Swiss presence to Geneva.